Stay updated with breaking news from Prct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lisanti Capital Growth LLC acquired a new position in PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 121,690 shares of the company’s stock, valued at approximately $5,100,000. PROCEPT BioRobotics makes up 1.2% of Lisanti Capital Growth LLC’s […] ....
Lisanti Capital Growth LLC acquired a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 121,690 shares of the company’s stock, valued at approximately $5,100,000. PROCEPT BioRobotics makes up about 1.2% of Lisanti Capital Growth LLC’s holdings, making the stock its […] ....
PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) and Autonomix Medical (NASDAQ:AMIX – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, institutional ownership, risk and earnings. Analyst Ratings This is a breakdown of recent […] ....
PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) has been assigned a consensus rating of “Buy” from the six ratings firms that are presently covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have updated their coverage on […] ....
Handelsbanken Fonder AB increased its stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 49.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 10,300 shares of the company’s stock after acquiring an additional 3,400 shares during the period. Handelsbanken Fonder AB’s holdings in PROCEPT BioRobotics were worth $432,000 as of its […] ....